Replies to post #747903 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The SOC has not progressed. What’s your point?

[CaptainObvious]

Maybe it won't be on his radar until approval. I could see not counting chickens before they hatch.

[QL300]

I would take that statement with a grain of salt. They're asking for support of their future cancer plan. That can explain the choice of words. While DCVAX moves the needle slightly, I don't believe it's anywhere good enough to be touted as anywhere close to a cure. There's not much of a difference between no progress and little progress for politicians who have a career of puffery. 

[meirluc]

Why did Minister Andrew Gwynne just now zero in specifically on brain
tumors as an area where things have not progressed at all? If he had
received information that DCVax-L is useless or has limited potential,
what would have been the purpose of mentioning now the long standing lack
of progress in the treatment of brain tumors? I also believe that the Minister
would not have made the statement if he had been of the opinion that
DCvax-L's efficacy is very limited?

Also, since we, the MB posters have information about the capacity of DCVax-L to be
potentiated ( e.g. polyICLC, Keytruda), does anyone believe that Minister Andrew
Gwynne knows less than we do?

Bottom line: I suspect that the Minister's statement at this time is an effort
to make the public aware of the importance of an effective brain tumor treatment
that will soon be introduced to the UK market.

[ilovetech]

I wouldn't put stock in any rhetoric coming from the mouths of the political class here in the US or the UK, at this juncture particularly. I'll leave it there.

[Steady_T]

Politicians say what serves them best.

To be generous, he is probably saying that because there are no new approved treatments in a long time.

It is unlikely that he is aware of NWBO and it's application. Even if he is aware it would be an unwise form him to assume that NWBO is going to be approved. That would imply that he has inside information about MHRA that should not be made public. That would also imply that MHRA has already made a decision.

As was almost pointed out, the new guidance being formulated relating to individualized cancer treatments relates to mRNA based treatments which does not apply to DCVax-l.